ATE556088T1 - Konjugat beinhaltend cephalosporin und glykopeptidantibiotikum - Google Patents

Konjugat beinhaltend cephalosporin und glykopeptidantibiotikum

Info

Publication number
ATE556088T1
ATE556088T1 AT03755467T AT03755467T ATE556088T1 AT E556088 T1 ATE556088 T1 AT E556088T1 AT 03755467 T AT03755467 T AT 03755467T AT 03755467 T AT03755467 T AT 03755467T AT E556088 T1 ATE556088 T1 AT E556088T1
Authority
AT
Austria
Prior art keywords
compounds
glycopeptide antibiotic
conjugate containing
containing cephalosporin
cephalosporin
Prior art date
Application number
AT03755467T
Other languages
English (en)
Inventor
Daniel Marquess
Martin Linsell
Derek Turner
Sean Trapp
Daniel Long
Paul Fatheree
Original Assignee
Theravance Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance Inc filed Critical Theravance Inc
Application granted granted Critical
Publication of ATE556088T1 publication Critical patent/ATE556088T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
AT03755467T 2002-05-24 2003-05-23 Konjugat beinhaltend cephalosporin und glykopeptidantibiotikum ATE556088T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38327402P 2002-05-24 2002-05-24
PCT/US2003/016375 WO2003099858A1 (en) 2002-05-24 2003-05-23 Cross-linked glycopeptide-cephalosporin antibiotics

Publications (1)

Publication Number Publication Date
ATE556088T1 true ATE556088T1 (de) 2012-05-15

Family

ID=29584538

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03755467T ATE556088T1 (de) 2002-05-24 2003-05-23 Konjugat beinhaltend cephalosporin und glykopeptidantibiotikum

Country Status (8)

Country Link
US (4) US6878686B2 (de)
EP (1) EP1507796B1 (de)
JP (2) JP4347799B2 (de)
AT (1) ATE556088T1 (de)
AU (1) AU2003231833A1 (de)
ES (1) ES2384707T3 (de)
TW (1) TWI325323B (de)
WO (1) WO2003099858A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2201825T3 (es) * 1998-12-23 2004-03-16 Theravance, Inc. Derivados del glicopeptidos y composiciones farmaceuticas que los contienen.
TWI335332B (en) * 2001-10-12 2011-01-01 Theravance Inc Cross-linked vancomycin-cephalosporin antibiotics
TWI325323B (en) * 2002-05-24 2010-06-01 Theravance Inc Cross-linked glycopeptide-cephalosporin antibiotics
JP2007500222A (ja) 2003-05-23 2007-01-11 セラヴァンス インコーポレーテッド 架橋グリコペプチド−セファロスポリン抗生物質
WO2005005436A2 (en) * 2003-07-11 2005-01-20 Theravance, Inc. Cross-linked glycopeptide-cephalosporin antibiotics
US20080020961A1 (en) * 2006-07-21 2008-01-24 Rodrigues Klin A Low Molecular Weight Graft Copolymers
US20110177617A1 (en) * 2009-05-29 2011-07-21 Claudia Bich Cross-linking reagents for molecular interactions analysis
US20140171357A1 (en) * 2011-03-24 2014-06-19 Seachaid Pharmaceuticals, Inc. Vancomycin derivatives
JP6151257B2 (ja) 2011-09-09 2017-06-21 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． 肺内感染症の治療方法
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
MX351963B (es) 2013-03-13 2017-11-06 Theravance Biopharma Antibiotics Ip Llc Forma cristalina de una sal de ácido tiazolilacético sustituido y trietilamina.
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140274993A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane-tazobactam pharmaceutical compositions
UA121298C2 (uk) 2013-03-15 2020-05-12 Мерк Шарп І Доум Корп. Антибіотична композиція на основі цефтолозану і тазобактаму
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
WO2023230205A1 (en) 2022-05-25 2023-11-30 Ikena Oncology, Inc. Mek inhibitors and uses thereof

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7A (en) 1836-08-10 Thomas blanchard
US5693A (en) 1848-08-01 Window-catch
US947926A (en) * 1908-09-15 1910-02-01 William C Meyer Expansion-reamer.
US4341775A (en) 1978-09-11 1982-07-27 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
GB2033377B (en) 1978-09-11 1983-05-05 Fujisawa Pharmaceuticalco Ltd Cephem compounds and processes for preparation thereof
US4220761A (en) 1978-09-12 1980-09-02 Fujisawa Pharmaceutical Co., Ltd. 7-[Substituted oximinoacetamido]-3-[hydroxy alkyltetrazolo]cephalosporin derivatives
JPS6041682A (ja) 1983-08-16 1985-03-05 Meiji Seika Kaisha Ltd 新規セフアロスポリン化合物及びその製造法
US4921851A (en) 1986-06-09 1990-05-01 Takeda Chemical Industries, Ltd. Cephem compounds, their production and use
AU1630988A (en) 1987-05-30 1988-12-01 Kyoto Pharmaceutical Industries, Ltd. Cephalosporin compound and pharmaceutical composition thereof
US5693791A (en) 1995-04-11 1997-12-02 Truett; William L. Antibiotics and process for preparation
EP1060189A1 (de) 1998-02-20 2000-12-20 Advanced Medicine, Inc. Glycopeptid-derivate als antibakterielle mittel
US6437119B1 (en) 1998-05-07 2002-08-20 William Lawrence Truett Compounds formed from two or three antibiotics and their processes of preparation
CA2319495A1 (en) 1998-06-08 1999-12-16 Advanced Medicine, Inc. Multibinding inhibitors of microsomal triglyceride transferase protein
US7208572B2 (en) * 1998-08-21 2007-04-24 Albany Medical College Leptin-related peptides
ES2201825T3 (es) 1998-12-23 2004-03-16 Theravance, Inc. Derivados del glicopeptidos y composiciones farmaceuticas que los contienen.
AU2001238020A1 (en) * 2000-02-04 2001-08-14 Advanced Medicine, Inc. Glycopeptide derivatives having antibiotic activity
UA75083C2 (uk) 2000-06-22 2006-03-15 Тераванс, Інк. Похідні глікопептидфосфонатів
US20030008812A1 (en) * 2001-02-02 2003-01-09 Christensen Burton G. Glycopeptide derivatives
TWI335332B (en) 2001-10-12 2011-01-01 Theravance Inc Cross-linked vancomycin-cephalosporin antibiotics
TWI325323B (en) * 2002-05-24 2010-06-01 Theravance Inc Cross-linked glycopeptide-cephalosporin antibiotics
JP2007500222A (ja) 2003-05-23 2007-01-11 セラヴァンス インコーポレーテッド 架橋グリコペプチド−セファロスポリン抗生物質
CA2469986A1 (en) * 2003-06-06 2004-12-06 Hagen, Hans T., Iii Insulated stud panel and method of making such
WO2005005436A2 (en) 2003-07-11 2005-01-20 Theravance, Inc. Cross-linked glycopeptide-cephalosporin antibiotics

Also Published As

Publication number Publication date
AU2003231833A1 (en) 2003-12-12
US7405199B2 (en) 2008-07-29
EP1507796A1 (de) 2005-02-23
US20060025332A1 (en) 2006-02-02
US8084417B2 (en) 2011-12-27
TW200307556A (en) 2003-12-16
WO2003099858A1 (en) 2003-12-04
JP2009256358A (ja) 2009-11-05
TWI325323B (en) 2010-06-01
US6995138B2 (en) 2006-02-07
ES2384707T3 (es) 2012-07-11
US20050209132A1 (en) 2005-09-22
JP4347799B2 (ja) 2009-10-21
US20040033939A1 (en) 2004-02-19
JP2006503805A (ja) 2006-02-02
US6878686B2 (en) 2005-04-12
EP1507796B1 (de) 2012-05-02
US20090137460A1 (en) 2009-05-28

Similar Documents

Publication Publication Date Title
ATE388153T1 (de) Quervernetzte glycopeptid-cephalosporin- antibiotika
ATE556088T1 (de) Konjugat beinhaltend cephalosporin und glykopeptidantibiotikum
ATE450540T1 (de) Quervernetzte glycopeptid-cephalosporin- antibiotika
ATE314376T1 (de) Kreuzverquerte glycopeptid-cephalosporin- antibiotika
TR200102128T2 (tr) Ketolid antibiyotikler
IL165715A0 (en) 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
MY139124A (en) Gyrase inhibitors and uses thereof
TW200734344A (en) Antibacterial agents
WO2006120563A3 (en) Antibacterial agents
DE60039238D1 (de) C-2-modifizierte erythromycinderivate
MX2010004407A (es) Antibioticos de carbacefem beta-lactama.
AP2003002942A0 (en) New derivatives of oxazolidinones as bacterial agents
BRPI0607701A2 (pt) composto ou um sal, éster, solvato, estereoisÈmero, tautÈmero ou pró-droga farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de uma quantidade antibacterialmente eficaz de um composto junto com um veìculo farmaceuticamente aceitável, e, método de preparação de um composto
PT1057828E (pt) Suspensoes de trovafloxacina para administracao oral
ATE339424T1 (de) 3-substituierte 7-alkylidene-3-cephem-4- carbonsäuren als beta-lactamase inhibitoren
WO2004098500A3 (en) CARBACEPHEM ss-LACTAM ANTIBIOTICS
UA83250C2 (ru) Применение тигециклина для лечения инфекций костей или костного мозга, инфекций суставов или тканей, окружающих сустав
NO20080314L (no) Bicykliske 6-alkyliden-penem B-laktamase inhibitorer og B-laktam antibiotisk kombinasjon: et bred spektret antibiotika
DE60207884D1 (de) Monobactam-antibakterielle verbindungen und anwendungsverfahren
BR0307468A (pt) Derivados tiadiazinona antimicrobianos úteis no tratamento de infecções bacterianas
ATE459368T1 (de) Glycopeptid-antibiotika
AU2001281657A1 (en) Therapeutic process for p. aeruginosa infections using macrolide antibiotics